Trial Information
Summary: Phase II, Clinical Trial For Patients with Prostate Cancer or Breast Cancer with Metastatic Disease
Open-Label Study to Evaluate the Safety and Effects on Bone
Resorption of Investigational Medication in Patients with Prostate
Cancer or Breast Cancer with Metastatic Disease
Patient Inclusion Criteria:
- Men 18 yrs or older with Confirmed Prostate Cancer
- Women 18 years or older with Confirmed Breast Cancer
- Confirmed Metastatic Bone Disease
Patient Exclusion Criteria:
- Brain Mets
- Prior exposure to Bisphosphonate Therapy
- Prior Treatment with Radiopharmaceuticals or Radiotherapy to
the Bone
|
Contact:
Cheryl Ahlstrom, Recruitment Manager
South Florida Medical Research
21150 Biscayne Blvd. #300
Aventura, FL 33180
Telephone: 305-931-8080 ext. 21
Fax: 305-931-8088
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 6:37:04 AM